ENRadiation is no substitute for surgery and chemotherapy in ovarian cancer, but in certain situations it helps. People look it up for one of two reasons: fear of the operation and a search for an alternative, or a relapse as a single spot that a doctor at home has suggested irradiating.
This page covers the place radiotherapy for ovarian cancer in Germany holds today, when doctors here actually prescribe it, what a course looks like and which questions radiation leaves unanswered. The wider picture is on the page about ovarian cancer treatment in Germany.
Why radiation is not the main treatment here
Radiation acts only where the beam is aimed, whereas ovarian cancer spreads across the whole abdominal cavity instead of growing as one lump in one place, and the whole abdomen cannot be irradiated at a dose that works on the tumour without harming the bowel, liver and kidneys. So the backbone remains ovarian cancer surgery removing all visible disease, plus platinum-based chemotherapy, to which this tumour responds.
Whole-abdominal irradiation was used decades ago and abandoned not to save money but because its complications, especially alongside chemotherapy, outweighed the benefit. The current German S3 guideline on malignant ovarian tumours confirms that it never became standard for these reasons and allows it only in clinical trials.
When radiation is used after all
Radiation is used for a single deposit, for symptoms and in unusual cases. First, an isolated relapse: one or two deposits after treatment — in a lymph node, the pelvic wall or near the scar — can be irradiated precisely at high doses over a few sessions; this is stereotactic radiotherapy. The aim is to deal with that one site and postpone a change of chemotherapy.
Second, symptom relief: a painful spinal metastasis, a bone deposit threatening a fracture, bleeding from a pelvic tumour, the rare brain metastasis. A few sessions often take the pain away and let the person return to ordinary life, though not always. The aim is how the patient feels, not a cure; for disease in distant organs, see the page on stage 4 ovarian cancer.
Third, rare ovarian tumour types and special situations where the tumour board raises the question of radiation. The gynaecological oncologist, radiation oncologist and medical oncologist decide together, never one specialist alone, and always on current imaging, not a three-month-old report.
How a course runs
Preparation comes first and cannot be rushed: a planning CT in the exact position the patient will lie in every day, skin marks, then the plan calculated by the doctor and a medical physicist. Several days usually pass between the first appointment and the first session, because the plan is made for this body and this tumour.
A session, positioning included, takes a few minutes to a quarter of an hour, is painless, needs no anaesthesia and is outpatient. The number of sessions depends on the aim: one to five for precise treatment or pain relief, up to several weeks of daily weekday visits for a large field.
Side effects depend on what lies in the field: for the pelvis, nausea, looser and more frequent stools, bladder irritation and tiredness that builds towards the end of the course; for a bone, usually few. All this is discussed before consent is given. Nor is radiation automatically combined with any chemotherapy: some drugs are paused for the duration.
Where it is done and what to ask
Radiotherapy is offered in university hospitals and in specialised practices. At the University Hospital Bonn, Prof. Eleni Gkika heads the Department of Radiotherapy and Radiation Oncology, and the hospital’s own Department of Gynaecology and Gynaecological Oncology eases a joint decision. Others include Ulm University Hospital’s department of the same name, the radiotherapy institute of the Asklepios Klinik St. Georg in Hamburg and the dedicated radiotherapy clinic in Munich-Pasing for outpatient courses. The Heidelberg Ion-Beam Therapy Center (HIT), under the medical direction of PD Dr. Semi Harrabi, stands apart: it takes questions about protons and carbon ions, but in ovarian cancer this is not a routine option and the tumour board decides.
Before agreeing, ask what the aim of the course is — to clear a deposit or to relieve pain — how many sessions it will take, what will be inside the field, how it fits with chemotherapy and who will follow the patient up at home.
Frequently asked questions
Can radiotherapy replace surgery for ovarian cancer?
No. Radiation works only where the beam is aimed, while ovarian cancer is usually scattered across the lining of the abdomen, so surgery and platinum-based chemotherapy remain the basis. If the operation frightens you, go through its extent, risks and recovery with a gynaecological oncologist. Radiation is kept for an isolated relapse, pain or bleeding.
Is radiotherapy given after surgery and chemotherapy to prevent a relapse?
No. The German guideline advises against consolidating the result with radiation once surgery and chemotherapy are complete: in trials it brought no reproducible gain in how long the disease stayed away or in survival. Maintenance treatment after chemotherapy today means drugs; radiation is kept for a relapse at a single site or for symptoms.
Can the same area be irradiated a second time?
Sometimes, but the radiation oncologist decides afresh. Organs near the target, such as the bowel, bladder or spinal cord, have already received part of the dose, so the doctor must know exactly how much was given and where. That is why the report with doses and fields from each course belongs with the medical records.
How AlenMed arranges a course
AlenMed starts with the documents: current CT or PET-CT images, histology, records of previous chemotherapy and the operation report are translated and sent to a German radiation oncologist, who says whether radiation makes sense here, how many sessions it would take and what imaging must be repeated on site. Then come a written estimate, a visa invitation, accommodation near the clinic for the whole course, as visits are daily, and an interpreter for discussing the aim of the course. What goes into the estimate is explained on the page about the cost of radiotherapy in Germany.
Plan ahead for a written session schedule, translated skin-care and diet advice, a contact for when side effects grow, and a final report with the exact doses and fields for the oncologist at home: without those numbers, irradiating the same area again cannot be planned.
This material is for information only and is not an offer. The indication and the dose are decided by a doctor after an in-person examination.
News on this topic
Charité treats first beta-thalassemia patient with CRISPR
At Berlin Charité, a 19-year-old beta-thalassemia patient became the first in Germany to receive the newly approved CRISPR gene therapy Exagamglogene Autotemcel.
Real-World Breast Cancer Study Confirms High Five-Year Survival Rates in Germany
A landmark study of over 43,000 German patients reveals a five-year invasive disease-free survival rate of 82.9 percent in early hormone receptor-positive breast cancer.
FDA Approves Jülich Diagnostic Radiotracer FET for Brain Tumor Imaging
The FDA approves the diagnostic radiotracer FET (Pixclara®) for evaluating brain gliomas, highlighting decades of neuro-oncology research at Forschungszentrum Jülich.
